$bioAffinity Technologies (BIAF.US)$ This company was also a...

$bioAffinity Technologies (BIAF.US)$ This company was also advertising on CNBC earlier this year when I bought in.  Why the investor webinar far between earnings reports?   Something is up.  They need to get SG&A under control.  I'm looking for a partnership with a major pharmaceutical to assist with the CyPath rollout. Less expensive to train the trainers.